CPT 38220 Billing Guide (2026)
- Med Cloud MD
- 3 days ago
- 9 min read

TABLE OF CONTENTS | |
01 → What Is CPT 38220? | 02 → When to Report CPT 38220 |
03 → Documentation Requirements | 04 → Billing Guidelines & Workflow |
05 → Modifiers for CPT 38220 | 06 → NCCI Bundling Rules |
07 → Common Billing Mistakes | 08 → Documentation vs. Denial Risk |
09 → 2026 Reimbursement Insights | 10 → Expert Billing Insights |
11 → Why Choose MedCloudMD | 12 → FAQ Section |
⚡ QUICK ANSWER: What Is CPT 38220? CPT 38220 is the procedure code for bone marrow aspiration only. The physician inserts a specialized needle — typically into the posterior superior iliac spine — and withdraws a liquid marrow specimen for cytological and hematological analysis. It is used to diagnose and monitor conditions including leukemia, lymphoma, multiple myeloma, aplastic anemia, MDS, and unexplained cytopenias. CPT 38220 covers the aspiration procedure only. It does NOT include the core biopsy (CPT 38221), pathology interpretation, flow cytometry, cytogenetics, or molecular testing — each of which requires its own separate code. Critical rule: When both aspiration AND core biopsy are performed in the same session at the same site, do NOT bill 38220 + 38221 — use CPT 38222 instead. |
Bone marrow aspiration is one of the most diagnostically significant procedures in hematology and CPT 38220 is the code that captures it. But despite how commonly this procedure is performed, its billing generates a disproportionate number of denials, audits, and reimbursement delays across hematology practices, oncology groups, and hospital outpatient departments nationwide.
The problem is rarely the procedure itself. It is the billing around it: aspiration and biopsy billed separately when CPT 38222 should have been used; documentation that describes the procedure without linking it to a supported diagnosis; modifier applications that don't match the actual service and billing arrangement; or a procedure note so generic it fails to satisfy payer documentation requirements.
This 2026 guide was written for hematology practices, laboratory directors, hospital billing teams, and revenue cycle professionals who want a clear, practical, compliance-grounded reference for CPT 38220 covering every stage from documentation and coding to modifiers, bundling, denial prevention, and reimbursement factors.
Revenue Insight In 2026, hematology practices that fail to distinguish between CPT 38220, 38221, and 38222 are losing recoverable revenue on every session where both aspiration and biopsy are performed. The NCCI bundling rule that applies when both are done at the same site is among the most frequently violated in hematology coding — and most violations are not caught until a payer audit flags the pattern. |
01 — What Is CPT 38220? Procedure Overview & Clinical Context
CPT 38220 describes bone marrow aspiration a procedure where the physician uses a dedicated aspiration needle to extract a small volume of liquid bone marrow from a patient, typically from the posterior superior iliac spine (PSIS), although the sternum and other sites are used in specific clinical contexts.
The extracted marrow is then sent to the laboratory for processing and analysis, which may include morphological evaluation, flow cytometry, cytogenetics, FISH studies, molecular profiling, or microbiological cultures depending on the clinical question being investigated. These subsequent laboratory analyses are each billed with their own separate CPT codes they are not included in CPT 38220.
The physician performing CPT 38220 is responsible for patient preparation, site selection, local anesthesia administration, the aspiration technique itself, specimen handling and labeling, and post-procedure assessment. The clinical judgment involved in selecting the procedure site and managing complications is part of the physician work value assigned to this code.
Did You Know? CPT 38222 was introduced specifically to correct the widespread industry practice of billing CPT 38220 + CPT 38221 together when both aspiration and biopsy were performed in the same session. The NCCI edit that bundles these two codes exists because CPT 38222 was created as the single correct code for the combined procedure. Practices still billing 38220 + 38221 together are not just getting denials they may be receiving inappropriate payment on the claims that do process, creating overpayment liability. |
02 — When Should CPT 38220 Be Reported?
The clinical scenarios that justify reporting CPT 38220 are well-defined and payer-audited. The ICD-10 code linked to the claim must directly reflect the documented clinical reason the procedure was ordered. Here are the most common appropriate use cases:
Compliance Alert: Preventive or Routine Aspiration Neither Medicare nor most commercial payers cover bone marrow aspiration performed for preventive, screening, or routine monitoring purposes without a documented active clinical indication. The diagnosis on the claim must represent an active condition under evaluation or management — not a 'history of' code unless the aspiration is specifically monitoring for recurrence with documented clinical rationale. |
03 — CPT 38220 Documentation Requirements
In hematology billing, the procedure note is your first line of defense against denials, audits, and payment recoupment. Payers performing post-payment audits on high-value hematology procedures look for specific documentation elements — and the absence of any one of them creates a recoverable overpayment finding.
Documentation Pro Tip The most common audit finding for CPT 38220 is a procedure note that describes the aspiration generically without specifying the site, number of pulls, specimen disposition, or the clinical link between the diagnosis and the procedure. A note that reads 'bone marrow aspiration performed without complications' will not survive a payer audit. The procedure note must read as if written to defend the claim because it may eventually need to. |
04 — CPT 38220 Billing Guidelines: Complete Step-by-Step Workflow
Correct CPT 38220 billing requires discipline at every step, from the moment the procedure is ordered to the day payment is posted. This is the workflow that high-performing hematology billing operations follow in 2026:
Modifiers for CPT 38220 — When and How to Apply Them
Modifier | Description | When to Apply with CPT 38220 | Common Error |
26 | Professional Component | Physician performs and interprets; facility separately bills technical component | Billing with no modifier when physician-owned office bills both components correct if global billing applies |
TC | Technical Component | Facility or independent lab bills for equipment, supplies, and technical staff only | Billing TC when physician does not have a separate professional component arrangement |
59 | Distinct Procedural Service | Aspiration performed at a separate anatomical site or a separate session from a biopsy | Applying 59 when procedures were actually same site creates NCCI override without documentation |
22 | Increased Procedural Services | Procedure was significantly more complex than standard — additional time/resources documented | Using 22 without documentation of specific added complexity — routinely denied without supporting notes |
25 | Separate E/M Same Day | Apply to E/M code (not 38220) when a separately documented E/M service occurred same day | Not using 25 on the E/M when E/M and procedure are both billed same day — causes E/M denial |
LT / RT | Left / Right Laterality | Bilateral aspiration at distinctly separate sites document both site locations explicitly | Applying bilateral modifiers to a standard single-site aspiration incorrect and creates overpayment |
NCCI Bundling Rules — What You Cannot Bill Together
Code Combination | NCCI Status | Correct Approach |
CPT 38220 + CPT 38221 (same site, same session) | BUNDLED — edit applies | Use CPT 38222 instead; 38220 will be denied if billed with 38221 |
CPT 38220 + CPT 38221 (different site, same session) | May be separately reported | Require modifier 59 on secondary code + explicit documentation of two distinct sites |
CPT 38220 + E/M code (same day) | Allowable with modifier | Add modifier 25 to the E/M code if a separately documented evaluation occurred same day |
CPT 38220 + CPT 85097 (interpretation) | Separately reportable | Physician interpretation is a distinct service — bill 85097 separately when performed |
CPT 38220 + anesthesia code | Context-dependent | Moderate sedation (99152–99153) may be separately reported; verify payer policy |
CPT 38220 + flow cytometry (e.g., 88184) | Separately reportable | Lab analysis codes are separate from the aspiration procedure do not bundle |
07 — Common CPT 38220 Billing Mistakes
These are the billing errors most commonly identified during hematology coding audits. Each one has a direct, measurable impact on practice revenue and each one is preventable with the right controls in place.
08 — Documentation vs. Denial Risk: Element-by-Element Analysis
Every missing documentation element creates a specific, predictable denial risk. This table maps the most critical elements to the exact denial type they trigger giving your billing team a clear priority list for documentation audits.
Documentation Element | Denial Risk If Missing or Incomplete | Recommended Best Practice |
Signed informed consent | Claim flagged on audit; may trigger full episode denial | Store signed consent in procedure record; confirm before billing |
Procedure site specificity | Documentation insufficient denial; NCCI modifier issue | Always name the exact site (e.g., Left PSIS) in the procedure note |
Medical necessity linkage | Non-covered service denial; LCD non-compliance finding | Physician notes must name the clinical indication and link it to the procedure |
Number of aspiration pulls | Physician work value questioned; audit finding | Document specific number of pulls and any difficulties encountered |
Pathology requisition | Lab claim correlation questioned during audit | Include requisition in claim documentation packet |
Post-procedure assessment | Incomplete note finding; potential claim denial | Document patient tolerance, hemostasis achieved, discharge instructions |
ICD-10 in physician notes | Diagnosis-claim mismatch denial on cross-audit | Diagnosis on claim must appear verbatim or equivalently in physician documentation |
Physician signature with date | Unsigned note = invalid per CMS guidelines | All procedure notes signed and dated same day or within CMS timely completion window |
09 — CPT 38220 Reimbursement Insights (2026)
CPT 38220 reimbursement varies significantly based on how and where it is billed. Understanding the factors that influence payment rather than relying on published rate estimates that may be outdated or jurisdiction-specific is the more reliable approach to revenue planning.
Revenue Planning Tip Never use published rate guides as revenue projections for CPT 38220. Rates vary by payer, geography, billing arrangement, and documentation quality. Use your actual ERA/EOB payment data to calculate payer-specific effective rates for this code then benchmark against your contracted rates to identify underpayment patterns. Systematic underpayments on high-value procedures like bone marrow aspiration are often not caught for months without this analysis. |
10 — Expert Billing Insights from MedCloudMD
These observations come from direct experience managing hematology billing operations across multiple practice types and payer environments. They reflect patterns our billing team sees repeatedly and the practical fixes that address them.
Insight #1: The 38220 + 38221 Problem Is Still the Top Denial Driver Despite the fact that CPT 38222 was introduced years ago, our team still encounters hematology practices billing 38220 and 38221 together when both procedures are performed in the same session. When we pull 12-month denial data for new hematology clients, this bundling error is frequently in the top three denial reasons by volume. The fix is straightforward — but it requires updating both the coder's workflow and the billing system's edit library. |
Insight #2: Procedure Notes Are Written for Clinicians, Not Payers Most procedure note templates were designed to communicate clinical findings to the care team — not to defend a billing claim. When we audit bone marrow aspiration notes, we commonly find excellent clinical content but missing billing-critical elements: no site specificity, no number of pulls, no post-procedure assessment, no explicit link between the diagnosis and the clinical need for the procedure. A one-time template revision typically resolves this across all providers. |
Insight #3: Medicare Advantage Plans Are the Highest Denial Risk Payers In our experience, Medicare Advantage plans deny CPT 38220 at a higher rate than traditional Medicare often for prior authorization failures that were not identified at the time the procedure was scheduled. The authorization requirements for bone marrow procedures vary significantly across MA plans, and many practices are using the same eligibility workflow for MA and traditional Medicare without recognizing the difference. A separate MA prior auth verification step prevents most of these denials. |
Insight #4: Underpayments on CPT 38220 Go Undetected Without Systematic Review Bone marrow aspiration reimbursement is high enough that even a 10–15% underpayment from one commercial payer adds up to thousands of dollars monthly across a high-volume hematology practice. Our team identifies these gaps through automated ERA analysis comparing payment amounts against contracted fee schedule rates. In almost every new client engagement, we find at least one payer systematically underpaying on bone marrow procedure codes — often for 12 months or longer before it was flagged. |
11 — Why Hematology Practices Choose MedCloudMD
MedCloudMD specializes in medical billing and revenue cycle management for hematology practices, oncology groups, and clinical laboratories across the United States. Our hematology billing team understands the nuances of bone marrow procedure coding the 38220/38222 distinction, modifier applications, LCD requirements, and MA plan authorization rules that general billing companies typically do not.
When you partner with MedCloudMD, you're not adding a billing vendor. You're adding a revenue cycle operation built for the complexity of hematology with the coding expertise, denial management infrastructure, and real-time reporting capability to improve your clean claim rate, recover denied revenue, and give your clinical team full visibility into billing performance.
Learn more about our hematology billing services: medcloudmd.com/specialties/hematology-billing-services
12 — Frequently Asked Questions — CPT 38220 Billing & Coding
These questions address the most common knowledge gaps in CPT 38220 billing. Answers reflect 2026 coding standards, CMS guidelines, and payer best practices.
DISCLAIMER This article is intended for educational and informational purposes only. The content provided by MedCloudMD does not constitute legal, compliance, financial, or coding advice. CPT codes, billing guidelines, Medicare policies, and payer requirements are subject to change. Always verify current coding rules with the AMA CPT manual, CMS guidelines, and individual payer policies before submitting claims. MedCloudMD makes no representations as to the accuracy or completeness of information presented here with respect to your specific billing circumstances. CPT codes are copyrighted by the American Medical Association (AMA). Use of CPT codes in this article is for educational reference only and does not imply authorization by the AMA beyond general educational use. Reimbursement rates mentioned reflect general factors and should not be used as financial projections. Consult a qualified healthcare attorney, compliance officer, or certified coding professional for guidance specific to your practice. |




Comments